BCL2 protein expression parallels its mRNA level in normal and malignant B cells.

The regulation of B-cell lymphoma 2 (BCL2) protein expression in germinal center (GC) B cells has been controversial. Previous reports have indicated posttranscriptional regulation plays a dominant role. However, a number of recent studies contradicted these reports. Using real-time polymerase chain reaction (PCR) and Standardized Reverse Transcriptase-PCR (StaRT-PCR), we measured the level of mRNA expression in GC, mantle zone (MNZ), and marginal zone (MGZ) cells from laser capture microdissection. Both quantitative RT-PCR measurements of microdissected GC cells from tonsils showed that GC cells had low expression of BCL2 transcripts commensurate with the low protein expression level. These results are in agreement with microarray studies on fluorescence-activated cell sorter (FACS)-sorted cells and microdissected GC cells. We also examined BCL2 mRNA and protein expression on a series of 30 cases of diffuse large B-cell lymphoma (DLBCL) and found, in general, a good correlation. The results suggested that BCL2 protein expression is regulated at the transcriptional level in normal B cells and in the neoplastic cells in most B-cell lymphoproliferative disorders.

[1]  L. Staudt,et al.  Two newly characterized germinal center B-cell-associated genes, GCET1 and GCET2, have differential expression in normal and neoplastic B cells. , 2003, The American journal of pathology.

[2]  Andrea Califano,et al.  Transcriptional analysis of the B cell germinal center reaction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Ash A. Alizadeh,et al.  The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile. , 2002, Blood.

[4]  Y. Tu,et al.  Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.

[5]  T. McDonnell,et al.  NF-κB1 (p50) Homodimers Contribute to Transcription of thebcl-2 Oncogene* , 2001, The Journal of Biological Chemistry.

[6]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[7]  R. Gascoyne,et al.  Bcl-6 and Bcl-2 protein expression in diffuse large B-cell lymphoma and follicular lymphoma: correlation with 3q27 and 18q21 chromosomal abnormalities. , 1999, Human pathology.

[8]  J. Camonis,et al.  Aiolos transcription factor controls cell death in T cells by regulating Bcl‐2 expression and its cellular localization , 1999, The EMBO journal.

[9]  R. Lutz,et al.  A Potent Cell Death Activity Associated with Transient High Level Expression of BCL-2* , 1998, The Journal of Biological Chemistry.

[10]  D. Latchman,et al.  Bcl-2 Transcription from the Proximal P2 Promoter Is Activated in Neuronal Cells by the Brn-3a POU Family Transcription Factor* , 1998, The Journal of Biological Chemistry.

[11]  L. Boxer,et al.  The WT1 Protein Is a Negative Regulator of the Normalbcl-2 Allele in t(14;18) Lymphomas* , 1997, The Journal of Biological Chemistry.

[12]  C. Franceschi,et al.  Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of BCL-2 expression and Myb-dependent regulation of bcl-2 promoter activity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Banchereau,et al.  Germinal Center Founder Cells Display Propensity for Apoptosis before Onset of Somatic Mutation , 1997, The Journal of experimental medicine.

[14]  L. Boxer,et al.  Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis , 1996, Molecular and cellular biology.

[15]  K. Rajewsky.  Clonal selection and learning in the antibody system , 1996, Nature.

[16]  J. Banchereau,et al.  Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2 , 1996, The Journal of experimental medicine.

[17]  Huei-Mei Chen,et al.  Pi 1 binding sites are negative regulators of bcl-2 expression in pre-B cells , 1995, Molecular and cellular biology.

[18]  John Calvin Reed,et al.  Identification of a p53-dependent negative response element in the bcl-2 gene. , 1994, Cancer research.

[19]  T. Yoshino,et al.  Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues. , 1994, Leukemia & lymphoma.

[20]  R. Warnke,et al.  Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues. , 1993, Blood.

[21]  T. Yoshino,et al.  Detection of bcl-2 protein and bcl-2 messenger RNA in normal and neoplastic lymphoid tissues by immunohistochemistry and in situ hybridization. , 1992, Blood.

[22]  S. Korsmeyer,et al.  Alternative promoters and exons, somatic mutation and deregulation of the Bcl‐2‐Ig fusion gene in lymphoma. , 1988, The EMBO journal.

[23]  J. Sklar,et al.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.

[24]  P. Nowell,et al.  Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. , 1984, Science.

[25]  Donna Neuberg,et al.  Center B Cells Using Cdna Arrays Gene Expression Profiling of Follicular Lymphoma and Normal Germinal , 2002 .

[26]  T. McDonnell,et al.  NF-kappaB1 (p50) homodimers contribute to transcription of the bcl-2 oncogene. , 2001, The Journal of biological chemistry.

[27]  Ch'en Cl,et al.  Rel/NF-kappaB represses bcl-2 transcription in pro-B lymphocytes. , 1999 .

[28]  M. Byrom,et al.  Rel/NF-kappaB represses bcl-2 transcription in pro-B lymphocytes. , 1999, Gene expression.